Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
The Multi-Target Respiratory Specimen Nucleic Acid Test Including SARS-CoV-2 and Other Microbial Agents is an in vitro diagnostic device intended to detect and identify SARS-CoV-2 and other microbial agents in human clinical respiratory specimens from patients suspected of respiratory infection, aiding in diagnosis in conjunction with clinical, epidemiologic, and laboratory data. This device is classified as FDA Class 2, requiring 510(k) clearance, under regulation 866.3981 in the Microbiology specialty. It carries product code QOF and is not an implant and not life-sustaining.
Research product code QOF in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QOF
- Device Class
- FDA class 2
- Regulation Number
- 866.3981
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 1
Device Characteristics
Definition
A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 33 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K252932 | Fast PCR Mini Respiratory Panel | Jun 12, 2026 | Substantially Equivalent | Autonomous Medical Devices Incorporated |
| K252269 | FINDER Flu A&B/SARS-CoV-2 Test | Mar 30, 2026 | Substantially Equivalent | Baebies, Inc. |
| K251742 | VELO Respiratory Test | Feb 13, 2026 | Substantially Equivalent | Lex Diagnostics Limited |
| K251978 | LIAISON NES FLU A/B, RSV & COVID-19 | Dec 23, 2025 | Substantially Equivalent | Diasorin Molecular, LLC |
| K252387 | Simplexa COVID-19/ Flu A/B & RSV Direct (MOL4450); Simplexa COVID-19/ Flu A/B & RSV Positive Control Pack (MOL4460) | Oct 30, 2025 | Substantially Equivalent | Diasorin Molecular, LLC |
| K250080 | QIAstat-Dx Respiratory Panel Plus; QIAstat-Dx Respiratory Panel Mini | Aug 27, 2025 | Substantially Equivalent | QIAGEN GmbH |
| K243544 | BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini | Aug 14, 2025 | Substantially Equivalent | Biofire Diagnostics, LLC |
| K243455 | cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems | Jul 31, 2025 | Substantially Equivalent | Roche Molecular Systems, Inc. |
| K250996 | Xpert Xpress CoV-2/Flu/RSV plus | May 01, 2025 | Substantially Equivalent | Cepheid® |
| K250995 | Xpert Xpress CoV-2/Flu/RSV plus | May 01, 2025 | Substantially Equivalent | Cepheid® |
| K243406 | cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test | Apr 25, 2025 | Substantially Equivalent | Roche Molecular Systems, Inc. |
| K243400 | cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test | Apr 25, 2025 | Substantially Equivalent | Roche Molecular Systems, Inc. |
| K242526 | Visby Medical Respiratory Health Test | Feb 19, 2025 | Substantially Equivalent | Visby Medical, Inc. |
| K241573 | Alinity m Resp-4-Plex | Feb 14, 2025 | Substantially Equivalent | Abbott Molecular, Inc. |
| K242071 | Xpert Xpress CoV-2/Flu/RSV plus | Jan 10, 2025 | Substantially Equivalent | Cepheid |
| K241806 | Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel | Jan 08, 2025 | Substantially Equivalent | Life Technologies Corporation |
| K241652 | DASH® SARS-CoV-2 & Flu A/B Test | Dec 20, 2024 | Substantially Equivalent | Nuclein, LLC |
| K242465 | Panther Fusion SARS-CoV-2/Flu A/B/RSV assay | Nov 15, 2024 | Substantially Equivalent | Hologic, Inc. |
| K242353 | QIAstat-Dx Respiratory Panel Mini | Oct 25, 2024 | Substantially Equivalent | QIAGEN GmbH |
| K241240 | Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay | Jul 18, 2024 | Substantially Equivalent | Hologic, Inc. |
| K241194 | BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini | May 30, 2024 | Substantially Equivalent | Biofire Diagnostics, LLC |
| K233100 | QIAstat-Dx® Respiratory Panel Plus | May 10, 2024 | Substantially Equivalent | QIAGEN GmbH |
| K232954 | BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel | Mar 26, 2024 | Substantially Equivalent | Biofire Diagnostics, LLC |
| K231758 | NxTAG Respiratory Pathogen Panel v2 (NxTAG RPP v2) | Mar 11, 2024 | Substantially Equivalent | Luminex Molecular Diagnostics, Inc. |
| K233410 | LIAISON PLEX Respiratory Flex Assay | Mar 01, 2024 | Substantially Equivalent | Luminex Corporation |
| K231481 | Xpert Xpress CoV-2/Flu/RSV plus | Aug 17, 2023 | Substantially Equivalent | Cepheid® |
| K230956 | BD Respiratory Viral Panel for BD MAX System; BD Respiratory Viral Panel-SCV2 for BD MAX System | Jul 31, 2023 | Substantially Equivalent | Bd Integrated Diagnostic Solutions / |
| K223591 | cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System | Jul 27, 2023 | Substantially Equivalent | Roche Molecular Systems, Inc. |
| K222736 | Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay | May 16, 2023 | Substantially Equivalent | Hologic, Inc. |
| K230719 | BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini | Apr 13, 2023 | Substantially Equivalent | Biofire Diagnostics, LLC |
| K220963 | Simplexa COVID-19 & Flu A/B Direct | Mar 17, 2023 | Substantially Equivalent | Diasorin Molecular, LLC |
| K213954 | BIOFIRE SPOTFIRE Respiratory (R) Panel | Feb 03, 2023 | Substantially Equivalent | Biofire Diagnostics |
| DEN200031 | BioFire Respiratory Panel 2.1 (RP2.1) | Mar 17, 2021 | Unknown | Biofire Diagnostics, LLC |
FEI Numbers
This FDA classification entry is associated with 32 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 32 registration numbers. Click on an entry to view related FDA registrations.